Literature DB >> 2545550

Intermediates in the aerobic autoxidation of 6-hydroxydopamine: relative importance under different reaction conditions.

P Gee1, A J Davison.   

Abstract

Autoxidation of 6-hydroxydopamine (6-OHDA) proceeds through a balanced network of: transition metal ions, superoxide, hydrogen peroxide, hydroxyl radicals, and other species. The contribution of each to the reaction mechanism varies dramatically depending upon which scavengers are present. The contribution of each propagating intermediate increases when the involvement of others is diminished. Thus, superoxide (which is relatively unimportant when metal ions can participate) dominates the reaction when transition metal ions are bound (especially at higher pH), and it becomes essential in the simultaneous presence of catalase plus chelators. Transition metal ions participate more if superoxide is excluded; hydrogen peroxide becomes more important if both .O2- and metal ions are excluded; and hydroxyl radicals contribute more to the reaction mechanism if both H2O2 and .O2- are excluded. Superoxide dismutase inhibited strongly, by two distinct mechanisms: a high affinity mechanism (less than 13% inhibition) at catalytically effective concentrations, and a low affinity mechanism (almost complete inhibition at the highest concentrations) which depends upon both metal binding and catalytic actions. In the presence of DETAPAC catalytic concentrations of superoxide dismutase inhibited by over 98%. Conversely, metal chelating agents inhibited strongly in the presence of superoxide dismutase. When present alone they stimulated (like EDTA), inhibited (like desferrioxamine), or had little effect (like DETAPAC). Catalase which stimulated slightly but consistently (less than 5%) when added alone, inhibited 100% in the presence of superoxide dismutase + DETAPAC. However, in the absence of DETAPAC, catalase decreased inhibition by superoxide dismutase, yielding a 100% increase in reaction rate. Hydroxyl scavengers (formate, mannitol or glucose) alone produced little or no (less than 10%) inhibition, but inhibited by 30% in the presence of catalase + superoxide dismutase. Paradoxically, they stimulated the reaction in the presence of catalase + superoxide dismutase + DETAPAC.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2545550     DOI: 10.1016/0891-5849(89)90054-3

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  11 in total

1.  The involvement of ethanol in the free radical reaction of 6-hydroxydopamine.

Authors:  F F Oldfield; D L Cowan; A Y Sun
Journal:  Neurochem Res       Date:  1991-01       Impact factor: 3.996

2.  Differential toxicity of 6-hydroxydopamine in SH-SY5Y human neuroblastoma cells and rat brain mitochondria: protective role of catalase and superoxide dismutase.

Authors:  Javier Iglesias-González; Sofía Sánchez-Iglesias; Estefanía Méndez-Álvarez; Sarah Rose; Atsuko Hikima; Peter Jenner; Ramón Soto-Otero
Journal:  Neurochem Res       Date:  2012-07-22       Impact factor: 3.996

3.  Type 2 diabetes induced oxidative brain injury involves altered cerebellar neuronal integrity and elemental distribution, and exacerbated Nrf2 expression: therapeutic potential of raffia palm (Raphia hookeri) wine.

Authors:  Ochuko L Erukainure; Omamuyovwi M Ijomone; Olakunle Sanni; Michael Aschner; Md Shahidul Islam
Journal:  Metab Brain Dis       Date:  2019-06-14       Impact factor: 3.584

4.  Alterations in bioenergetic function induced by Parkinson's disease mimetic compounds: lack of correlation with superoxide generation.

Authors:  Brian P Dranka; Jacek Zielonka; Anumantha G Kanthasamy; Balaraman Kalyanaraman
Journal:  J Neurochem       Date:  2012-07-11       Impact factor: 5.372

5.  A microfluidic-based neurotoxin concentration gradient for the generation of an in vitro model of Parkinson's disease.

Authors:  Azadeh Seidi; Hirokazu Kaji; Nasim Annabi; Serge Ostrovidov; Murugan Ramalingam; Ali Khademhosseini
Journal:  Biomicrofluidics       Date:  2011-06-29       Impact factor: 2.800

6.  Neuroprotective mechanism of mitochondrial ferritin on 6-hydroxydopamine-induced dopaminergic cell damage: implication for neuroprotection in Parkinson's disease.

Authors:  Zhen-Hua Shi; Guangjun Nie; Xiang-Lin Duan; Tracey Rouault; Wen-Shuang Wu; Bo Ning; Nan Zhang; Yan-Zhong Chang; Bao-Lu Zhao
Journal:  Antioxid Redox Signal       Date:  2010-09-15       Impact factor: 8.401

7.  Manganese superoxide dismutase protects against 6-hydroxydopamine injury in mouse brains.

Authors:  Jason Callio; Tim D Oury; Charleen T Chu
Journal:  J Biol Chem       Date:  2005-03-08       Impact factor: 5.157

8.  Dynamic expressions of Beclin 1 and tyrosine hydroxylase in different areas of 6-hydroxydopamine-induced Parkinsonian rats.

Authors:  Sheng Zhang; Zhong-Feng Xue; Li-Ping Huang; Ruo-Ming Fang; Yu-Ping He; Ling Li; Yong-Qi Fang
Journal:  Cell Mol Neurobiol       Date:  2013-07-19       Impact factor: 5.046

9.  6-Hydroxydopamine: a far from simple neurotoxin.

Authors:  Damir Varešlija; Keith F Tipton; Gavin P Davey; Andrew G McDonald
Journal:  J Neural Transm (Vienna)       Date:  2020-01-01       Impact factor: 3.575

10.  Mitochondrial dynamics and mitophagy in the 6-hydroxydopamine preclinical model of Parkinson's disease.

Authors:  Maria F Galindo; Maria E Solesio; Sandra Atienzar-Aroca; Maria J Zamora; Joaquín Jordán Bueso
Journal:  Parkinsons Dis       Date:  2012-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.